Our history

1886

GSK heritage companies have operated in Australia since 1886.

1924

Australian branch of Wellcome Foundation registered as Burroughs Wellcome & Company (Australia), establishing a research-based industry in Australia.

1961

Glaxo Boronia facility founded and expanded in various stages over the next four decades.

1964

Poppy growing project starts in Tasmania and develops into one of Australia’s greatest agricultural and manufacturing success stories.

1980

Wellcome Australia Medal, now the GlaxoSmithKline Award for Research Excellence is presented for the first time.

1989

Merger between Beecham Laboratories and Smith, Kline & French to form SmithKline Beecham.

1995

Merger between Glaxo and Burroughs Wellcome to form Glaxo Wellcome.

2000

Merger between Glaxo Wellcome and SmithKline Beecham to form GlaxoSmithKline (GSK).

2003

New ‘Australasia’ region formed, consisting of GSK Australia and New Zealand.

2005

Paul Lirette commences as Area Director Australasia & General Manager Australia.

2009

Deborah Waterhouse commences as General Manager Australia. GSK becomes a leader in skincare with the acquisition of Stiefel. GSK and Pfizer launch ViiV Healthcare, a company focused on delivering advances in treatment and care for HIV communities.

2012

Geoff McDonald commences as General Manager Australia.

2015

In March we acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. We also sold our opiates business to Sun Pharma.